|

Tigilanol Tiglate Clinical Trials

1 actively recruiting trial across 1 location

Also known as: EBC-46

Pipeline

Phase 2: 1

Top Sponsors

  • QBiotics Group Limited1

Indications

  • Soft Tissue Sarcoma1
  • Cancer1

New York, New York1 trial

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Centre

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.